These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 22492103)
21. Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group. ; Al Jasmi F; Al Jumah M; Alqarni F; Al-Sanna'a N; Al-Sharif F; Bohlega S; Cupler EJ; Fathalla W; Hamdan MA; Makhseed N; Nafissi S; Nilipour Y; Selim L; Shembesh N; Sunbul R; Tonekaboni SH BMC Neurol; 2015 Oct; 15():205. PubMed ID: 26471939 [TBL] [Abstract][Full Text] [Related]
22. Gingival overgrowth in Pompe disease: a case report. de Gijt JP; van Capelle CI; Oosterhuis JW; van der Ploeg AT; van der Wal KG J Oral Maxillofac Surg; 2011 Aug; 69(8):2186-90. PubMed ID: 21783002 [TBL] [Abstract][Full Text] [Related]
23. Pompe disease: a neuromuscular disease with respiratory muscle involvement. Mellies U; Lofaso F Respir Med; 2009 Apr; 103(4):477-84. PubMed ID: 19131232 [TBL] [Abstract][Full Text] [Related]
24. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258 [TBL] [Abstract][Full Text] [Related]
25. Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry. Kishnani PS; Amartino HM; Lindberg C; Miller TM; Wilson A; Keutzer J Mol Genet Metab; 2014; 113(1-2):84-91. PubMed ID: 25085280 [TBL] [Abstract][Full Text] [Related]
26. The Brazilian consensus on the management of Pompe disease. Llerena JC; Horovitz DM; Marie SK; Porta G; Giugliani R; Rojas MV; Martins AM; J Pediatr; 2009 Oct; 155(4 Suppl):S47-56. PubMed ID: 19765410 [No Abstract] [Full Text] [Related]
27. Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. Chien YH; Lee NC; Peng SF; Hwu WL Pediatr Res; 2006 Sep; 60(3):349-52. PubMed ID: 16857770 [TBL] [Abstract][Full Text] [Related]
28. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645 [TBL] [Abstract][Full Text] [Related]
29. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia. Pérez-López J; Selva-O'Callaghan A; Grau-Junyent JM; Gallego-Galindo L; Coll MJ; García-Morillo S; Torralba-Cabeza MA; Vilardell-Tarrés M Mol Genet Metab; 2015 Apr; 114(4):580-3. PubMed ID: 25752415 [TBL] [Abstract][Full Text] [Related]
30. [Myopathy associated with respiratory insufficiency: diagnostic difficulties in adult-onset Pompe disease]. Merkli H; Pál E; Nagy F; Horváth R; Várdi VK; Komoly S; Illés Z Orv Hetil; 2006 Jul; 147(30):1421-4. PubMed ID: 16977780 [TBL] [Abstract][Full Text] [Related]
31. Screening for late-onset Pompe disease in Finland. Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669 [TBL] [Abstract][Full Text] [Related]
32. New insights into therapeutic options for Pompe disease. Richard E; Douillard-Guilloux G; Caillaud C IUBMB Life; 2011 Nov; 63(11):979-86. PubMed ID: 22002928 [TBL] [Abstract][Full Text] [Related]
33. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease. Umapathysivam K; Hopwood JJ; Meikle PJ Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875 [TBL] [Abstract][Full Text] [Related]
34. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Müller-Felber W; Horvath R; Gempel K; Podskarbi T; Shin Y; Pongratz D; Walter MC; Baethmann M; Schlotter-Weigel B; Lochmüller H; Schoser B Neuromuscul Disord; 2007 Oct; 17(9-10):698-706. PubMed ID: 17643989 [TBL] [Abstract][Full Text] [Related]
35. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease. Douillard-Guilloux G; Richard E; Batista L; Caillaud C J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466 [TBL] [Abstract][Full Text] [Related]
36. [Adult form of Pompe disease]. Ziółkowska-Graca B; Kania A; Zwolińska G; Nizankowska-Mogilnicka E Pneumonol Alergol Pol; 2008; 76(5):396-9. PubMed ID: 19003770 [TBL] [Abstract][Full Text] [Related]
37. Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease. Orlikowski D; Pellegrini N; Prigent H; Laforêt P; Carlier R; Carlier P; Eymard B; Lofaso F; Annane D Neuromuscul Disord; 2011 Jul; 21(7):477-82. PubMed ID: 21550241 [TBL] [Abstract][Full Text] [Related]
38. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. Hundsberger T; Schoser B; Leupold D; Rösler KM; Putora PM J Neurol; 2019 Aug; 266(8):2010-2017. PubMed ID: 31104135 [TBL] [Abstract][Full Text] [Related]
39. Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype. Anneser JM; Pongratz DE; Podskarbi T; Shin YS; Schoser BG Neurology; 2005 Jan; 64(2):368-70. PubMed ID: 15668445 [TBL] [Abstract][Full Text] [Related]